A Letter from Allen Lee, Leader

The extraction and use of Ganoderma Applanatum mycelium has been researched for about 30 years. Through numerous clinical trials, the products holds obtained two international patents and was recognized as a natural product by the Canadian government in 2023.

This natural product is the first and only company to hold a patent utilizing Ganoderma Applanatum for treating diabetes. It contributes to healthy blood sugar levels, supports healthy glucose metabolism, and is a source of fungal polysaccharides with immunomodulating properties.

This natural product provides reduction and maintenance for pancreatic, lung, liver, breast, leukemia, lymph adenocarcinoma, and all other cancers. It is also a powerful treatment and solution for Type 1 & 2 Diabetes, all complications from Diabetes, and Diabetes prevention. It can also be used to treat incurable and rare diseases, heart cancer, Von Hippel Lindau syndrome / VHL, Reye Syndrome, Hemophilia Type 1 Diabetes Mellitus / IDDM, Hepatitis A Virus / HAV, Hepatitis B Virus / HBV, Hepatitis C Virus / HCV, Avian Influenza / AI, and other Autoimmune diseases.

We are confident that this natural product is revolutionary in the history of medicine that treats and prevents people and animals without any side effects on the human body or animals. It is my goal to make this medicine widely available to patients whose lives are threatened by diseases. Without side effects, this natural product works faster than any cure and can be used for all viruses and infections, including cancer. It is the safest and most effective treatment for people and can also be used safely on animals suffering from disease.

If you are a healthcare provider who is interested in partnering with us to provide this product and treatment to your patients, please contact us below.